« Previous
Next »
Biology of Blood and Marrow Transplantation
Volume 16, Issue 8
, Pages
1115-1121
, August 2010
Thalidomide-Dexamethasone as Induction Therapy before Autologous Stem Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma and Renal Insufficiency
-
Renal function before and after induction therapy in patients achieving (A) or not achieving (B) at least a PR.
Renal function before and after induction therapy in patients achieving (A) or not achieving (B) at least a PR.
-
EFS (dotted line) and OS (solid line) of patients enrolled in the study. Data were analyzed on an intention-to-treat basis.
EFS (dotted line) and OS (solid line) of patients enrolled in the study. Data were analyzed on an intention-to-treat basis.
-
EFS (A) and OS (B) of patients presenting with a baseline creatinine clearance of 30-50 mL/min and <30 mL/min.
EFS (A) and OS (B) of patients presenting with a baseline creatinine clearance of 30-50 mL/min and <30 mL/min.
Financial disclosure: See Acknowledgments on page 1120.
PII: S1083-8791(10)00093-5
doi: 10.1016/j.bbmt.2010.02.020
© 2010 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Biology of Blood and Marrow Transplantation
Volume 16, Issue 8
, Pages
1115-1121
, August 2010
